NEW YORK, April 03, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Plug Power, Inc. PLUG, Milacron Holdings Corp. MCRN, Genesis Healthcare, Inc. GEN, Jounce Therapeutics, Inc. JNCE, GW Pharmaceuticals PLC GWPH, and Earthstone Energy, Inc. ESTE, including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available to readers at the links below.
PLUG DOWNLOAD: http://MarketSourceResearch.com/register/?so=PLUG
MCRN DOWNLOAD: http://MarketSourceResearch.com/register/?so=MCRN
GEN DOWNLOAD: http://MarketSourceResearch.com/register/?so=GEN
JNCE DOWNLOAD: http://MarketSourceResearch.com/register/?so=JNCE
GWPH DOWNLOAD: http://MarketSourceResearch.com/register/?so=GWPH
ESTE DOWNLOAD: http://MarketSourceResearch.com/register/?so=ESTE
(You may have to copy and paste the link into your browser and hit the [ENTER] key)
The new research reports from Market Source Research, available for free download at the links above, examine Plug Power, Inc. PLUG, Milacron Holdings Corp. MCRN, Genesis Healthcare, Inc. GEN, Jounce Therapeutics, Inc. JNCE, GW Pharmaceuticals PLC GWPH, and Earthstone Energy, Inc. ESTE on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.
-----------------------------------------
Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.
-----------------------------------------
PLUG POWER, INC. (PLUG) REPORT OVERVIEW
Plug Power's Recent Financial Performance
For the three months ended December 31st, 2018 vs December 31st, 2017, Plug Power reported revenue of $58.27MM vs $29.54MM (up 97.24%) and analysts estimated basic earnings per share -$0.08 vs -$0.10. For the twelve months ended December 31st, 2018 vs December 31st, 2017, Plug Power reported revenue of $174.63MM vs $100.15MM (up 74.37%) and analysts estimated basic earnings per share -$0.36 vs -$0.60. Analysts expect earnings to be released on May 8th, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was -$0.07. The estimated EPS forecast for the next fiscal year is -$0.05 and is expected to report on March 5th, 2020.
To read the full Plug Power, Inc. (PLUG) report, download it here: http://MarketSourceResearch.com/register/?so=PLUG
-----------------------------------------
MILACRON HOLDINGS CORP. (MCRN) REPORT OVERVIEW
Milacron's Recent Financial Performance
For the three months ended December 31st, 2018 vs December 31st, 2017, Milacron reported revenue of $311.40MM vs $324.90MM (down 4.16%) and analysts estimated basic earnings per share $0.09 vs $0.05 (up 80.00%). For the twelve months ended December 31st, 2018 vs December 31st, 2017, Milacron reported revenue of $1,258.20MM vs $1,234.20MM (up 1.94%) and analysts estimated basic earnings per share $0.60 vs $0.02 (up 2,900.00%). Analysts expect earnings to be released on April 25th, 2019. The report will be for the fiscal period ending March 31st, 2019. Reported EPS for the same quarter last year was $0.40. The estimated EPS forecast for the next fiscal year is $1.80 and is expected to report on February 20th, 2020.
To read the full Milacron Holdings Corp. (MCRN) report, download it here: http://MarketSourceResearch.com/register/?so=MCRN
-----------------------------------------
GENESIS HEALTHCARE, INC. (GEN) REPORT OVERVIEW
Genesis Healthcare's Recent Financial Performance
For the three months ended December 31st, 2018 vs December 31st, 2017, Genesis Healthcare reported revenue of $1,185.95MM vs $1,327.88MM (down 10.69%) and analysts estimated basic earnings per share -$0.67 vs -$0.96. For the twelve months ended December 31st, 2018 vs December 31st, 2017, Genesis Healthcare reported revenue of $4,976.65MM vs $5,373.74MM (down 7.39%) and analysts estimated basic earnings per share -$2.33 vs -$6.15. Analysts expect earnings to be released on May 9th, 2019. The report will be for the fiscal period ending March 31st, 2019. Reported EPS for the same quarter last year was -$0.39. The estimated EPS forecast for the next fiscal year is -$0.94 and is expected to report on March 16th, 2020.
To read the full Genesis Healthcare, Inc. (GEN) report, download it here: http://MarketSourceResearch.com/register/?so=GEN
-----------------------------------------
JOUNCE THERAPEUTICS, INC. (JNCE) REPORT OVERVIEW
Jounce Therapeutics' Recent Financial Performance
For the three months ended December 31st, 2018 vs December 31st, 2017, Jounce Therapeutics reported revenue of $20.10MM vs $12.99MM (up 54.75%) and basic earnings per share -$0.07 vs -$0.31. For the twelve months ended December 31st, 2018 vs December 31st, 2017, Jounce Therapeutics reported revenue of $65.20MM vs $71.64MM (down 8.99%) and analysts estimated basic earnings per share -$0.84 vs -$0.57. Analysts expect earnings to be released on May 8th, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was -$0.40. The estimated EPS forecast for the next fiscal year is -$1.66 and is expected to report on March 4th, 2020.
To read the full Jounce Therapeutics, Inc. (JNCE) report, download it here: http://MarketSourceResearch.com/register/?so=JNCE
-----------------------------------------
GW PHARMACEUTICALS PLC (GWPH) REPORT OVERVIEW
GW Pharmaceuticals' Recent Financial Performance
For the three months ended September 30th, 2018 vs September 30th, 2017, GW Pharmaceuticals reported revenue of -$1.80MM vs $0.91MM and analysts estimated basic earnings per share -$3.74 vs -$2.17. For the twelve months ended September 30th, 2018 vs September 30th, 2017, GW Pharmaceuticals reported revenue of $12.74MM vs $8.63MM (up 47.61%) and analysts estimated basic earnings per share -$10.56 vs -$6.72. Analysts expect earnings to be released on May 14th, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was -$3.12. The estimated EPS forecast for the next fiscal year is -$2.16 and is expected to report on November 26th, 2019.
To read the full GW Pharmaceuticals PLC (GWPH) report, download it here: http://MarketSourceResearch.com/register/?so=GWPH
-----------------------------------------
EARTHSTONE ENERGY, INC. (ESTE) REPORT OVERVIEW
Earthstone Energy's Recent Financial Performance
For the three months ended December 31st, 2018 vs December 31st, 2017, Earthstone Energy reported revenue of $41.24MM vs $35.68MM (up 15.58%) and analysts estimated basic earnings per share $1.28 vs $0.12 (up 966.67%). For the twelve months ended December 31st, 2018 vs December 31st, 2017, Earthstone Energy reported revenue of $165.36MM vs $108.08MM (up 53.00%) and analysts estimated basic earnings per share $1.50 vs -$0.53. Analysts expect earnings to be released on May 2nd, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was $0.19. The estimated EPS forecast for the next fiscal year is $0.87 and is expected to report on March 10th, 2020.
To read the full Earthstone Energy, Inc. (ESTE) report, download it here: http://MarketSourceResearch.com/register/?so=ESTE
-----------------------------------------
ABOUT MARKET SOURCE RESEARCH
Market Source Research delivers the key research reports that helps serious investors, registered brokers, professional traders, and personal investment advisers find reliable information in today's markets. Market Source Research's team is comprised of financial professionals, many of which hold Chartered Financial Analyst® (CFA®) designations and FINRA® BrokerCheck® certifications. Whether identifying emerging trends, or discovering new opportunity, the team at Market Source Research is dedicated to providing accurate, informative, and objective content that's ahead of the curve. With insights on individual companies as well as sectors, readers get the industry's best available combination of big-picture perspective as well as granular detail.
REGISTERED MEMBER STATUS
Market Source Research's oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Market Source Research's roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Market Source Research have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Market Source Research's Compliance department by Phone, at +1 (704) 343-6361, or by E-mail at compliance@MarketSourceResearch.com.
LEGAL NOTICES
Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Market Source Research, Market Source Research members, and/or Market Source Research affiliates are not responsible for any gains or losses that result from the opinions expressed. Market Source Research makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Market Source Research has not been compensated for the publication of this press release by any of the above mentioned companies. Market Source Research is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.
Media Contact:
Jim Patterson, Media Department
Office: +1 (704) 343-6361
E-mail: media@MarketSourceResearch.com
© 2019 Market Source Research. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@MarketSourceResearch.com.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
